Colorado Nurse Loses DEA License: No Hearing, No Mercy
Published Date: 7/16/2025
Notice
Summary
Diana Clouthier, a nurse practitioner from Colorado, lost her DEA registration because she no longer has permission to handle controlled substances in her state. She didn’t ask for a hearing after being notified, so the DEA moved forward and officially revoked her registration. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for N.P.
The DEA revoked Diana Clouthier's Certificate of Registration No. MC5780639 and denied any pending applications to renew, modify, or obtain additional registration in Colorado. The Agency found her Colorado nursing licenses were suspended on October 21, 2024, and the Order takes effect August 15, 2025.
State License Loss Triggers DEA Revocation
Under 21 U.S.C. 824(a)(3) and related provisions cited in this Order, if a practitioner's State license or registration is suspended or revoked so that they are no longer authorized to handle controlled substances in that State, the DEA may revoke the practitioner's DEA registration. The Order cites this rule as the basis for revoking the registrant's DEA registration after Colorado suspended her licenses.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2025-13352, New Hampshire Department of Environmental Services; Notice of Application for Surrender of Exemption Accepted for Filing, Soliciting Comments, Motions To Intervene, and Protests
The New Hampshire Department of Environmental Services wants to give up a special exemption for the Squam Lake Dam Hydroelectric Project. This change could affect local energy rules and lets the public share their thoughts by August 12, 2025. If you care about the environment or energy in Grafton County, now’s the time to speak up!
Next: 2025-13365, Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Unmanned Aircraft Systems (UAS) and Their Parts and Components
The government is checking if importing drones and their parts could affect our national security. If you make, sell, or use drones, now’s your chance to share your thoughts before any new rules are made. Comments are open soon, so don’t miss out on helping shape the future of drone imports and trade!